Nu Med Plus Stock Market Value
| NUMD Stock | USD 0.05 0 5.71% |
| Symbol | NUMD |
Nu Med 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nu Med's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nu Med.
| 04/28/2025 |
| 07/27/2025 |
If you would invest 0.00 in Nu Med on April 28, 2025 and sell it all today you would earn a total of 0.00 from holding Nu Med Plus or generate 0.0% return on investment in Nu Med over 90 days. Nu Med is related to or competes with Vivos, Senseonics Holdings, and SANUWAVE Health,. Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of m... More
Nu Med Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nu Med's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nu Med Plus upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 43.0 | |||
| Value At Risk | (16.67) | |||
| Potential Upside | 15.37 |
Nu Med Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nu Med's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nu Med's standard deviation. In reality, there are many statistical measures that can use Nu Med historical prices to predict the future Nu Med's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | 0.2921 | |||
| Total Risk Alpha | (2.37) | |||
| Treynor Ratio | 0.0633 |
Nu Med Plus Backtested Returns
At this point, Nu Med is out of control. Nu Med Plus retains Efficiency (Sharpe Ratio) of 0.0202, which conveys that the firm had a 0.0202 % return per unit of price deviation over the last 3 months. We have found twenty-three technical indicators for Nu Med, which you can use to evaluate the volatility of the firm. Please verify Nu Med's Information Ratio of (0.04), market risk adjusted performance of 0.0733, and Mean Deviation of 5.15 to check out if the risk estimate we provide is consistent with the expected return of 0.16%. Nu Med has a performance score of 1 on a scale of 0 to 100. The company owns a Beta (Systematic Risk) of -2.15, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Nu Med are expected to decrease by larger amounts. On the other hand, during market turmoil, Nu Med is expected to outperform it. Nu Med Plus currently owns a risk of 7.96%. Please verify Nu Med Plus jensen alpha and the relationship between the value at risk and day typical price , to decide if Nu Med Plus will be following its current price history.
Auto-correlation | 0.09 |
Virtually no predictability
Nu Med Plus has virtually no predictability. Overlapping area represents the amount of predictability between Nu Med time series from 28th of April 2025 to 12th of June 2025 and 12th of June 2025 to 27th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nu Med Plus price movement. The serial correlation of 0.09 indicates that less than 9.0% of current Nu Med price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.09 | |
| Spearman Rank Test | -0.41 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Nu Med Plus lagged returns against current returns
Autocorrelation, which is Nu Med otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nu Med's otc stock expected returns. We can calculate the autocorrelation of Nu Med returns to help us make a trade decision. For example, suppose you find that Nu Med has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nu Med regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nu Med otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nu Med otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nu Med otc stock over time.
Current vs Lagged Prices |
| Timeline |
Nu Med Lagged Returns
When evaluating Nu Med's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nu Med otc stock have on its future price. Nu Med autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nu Med autocorrelation shows the relationship between Nu Med otc stock current value and its past values and can show if there is a momentum factor associated with investing in Nu Med Plus.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in NUMD OTC Stock
Nu Med financial ratios help investors to determine whether NUMD OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NUMD with respect to the benefits of owning Nu Med security.